Aldoss Osamah, Arain Nofil, Menk Jeremiah, Kochilas Lazaros, Gruenstein Daniel
Division of Pediatric Cardiology, Department of Pediatrics, University of Minnesota Amplatz Children's Hospital, Minneapolis, Minnesota.
Catheter Cardiovasc Interv. 2014 Jun 1;83(7):E272-6. doi: 10.1002/ccd.24413. Epub 2013 Dec 4.
To determine whether superior vena cava (SVC) stent implantation is superior to balloon angioplasty for relieving SVC stenosis.
SVC stent and balloon dilation have been used as treatment for SVC stenosis. Although safe and effective, outcome data comparing the two methods are limited.
A Pediatric Cardiac Care Consortium review identified SVC stenosis. Patients who required SVC intervention were divided into two subgroups-balloon dilation (Group A) and stent implantation (Group B). Logistic regression and the log-rank test were used to test the need for re-intervention within 6 months after the initial procedure.
SVC intervention was performed on 210/637 patients with SVC stenosis (33%). There were 108/210 (51%) patients with balloon dilation (Group A) and 102/210 (49%) with stent implantation (Group B). Re-intervention within 6 months of the initial intervention was more common in Group A compared to Group B [Group A = 31/40 (77.5%); Group B = 5/22 (22.7%)]. The odds-ratio for re-intervention within 6 months of the initial procedure for balloon vs. stent, is 7.3 [95% CI: (2.91, 22.3), P < 0.0001]. In addition, during the first 6 months after an intervention for SVC stenosis the proportion of patients with stent implantation that remained free of re-intervention was significantly higher than after balloon angioplasty (log-rank test, P < 0.0001). Neither age nor weight was significantly associated with the need for re-intervention.
SVC stent implantation is more effective than angioplasty in relief of SVC obstruction. Weight and age are not risk factors for early re-intervention.
确定上腔静脉(SVC)支架植入术在缓解SVC狭窄方面是否优于球囊血管成形术。
SVC支架和球囊扩张术已被用于治疗SVC狭窄。尽管这两种方法安全有效,但比较二者的疗效数据有限。
一项儿科心脏护理联盟综述确定了SVC狭窄病例。需要进行SVC干预的患者被分为两个亚组——球囊扩张组(A组)和支架植入组(B组)。采用逻辑回归和对数秩检验来检测初次手术后6个月内再次干预的必要性。
对210/637例(33%)SVC狭窄患者进行了SVC干预。其中108/210例(51%)患者接受球囊扩张(A组),102/210例(49%)患者接受支架植入(B组)。与B组相比,A组在初次干预后6个月内再次干预更为常见[A组=31/40(77.5%);B组=5/22(22.7%)]。初次手术后6个月内球囊扩张与支架植入相比再次干预的优势比为7.3[95%可信区间:(2.91,22.3),P<0.0001]。此外,在SVC狭窄干预后的前6个月内,接受支架植入的患者未再次干预的比例显著高于球囊血管成形术后(对数秩检验,P<0.0001)。年龄和体重均与再次干预的必要性无显著相关性。
SVC支架植入术在缓解SVC梗阻方面比血管成形术更有效。体重和年龄不是早期再次干预的危险因素。